Protective effect of tumor necrosis factor-α against subsequent endotoxemia in mice is mediated, in part, by interleukin-10

被引:23
作者
Murphey, ED [1 ]
Traber, DL
机构
[1] Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77550 USA
[2] Shriners Burns Hosp, Galveston, TX USA
关键词
rodent; endotoxin shock; inflammation; cytokines; in vivo animal model; tumor necrosis factor; interleukin-10; tolerance;
D O I
10.1097/00003246-200109000-00018
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Objective: Tumor necrosis factor (TNF)-alpha administration in large amounts can induce a state of shock similar to that observed in patients suffering from septic shock. Small doses of TNF-alpha induce only mild, transient hemodynamic alterations and can confer protection against subsequent inflammatory stimuli, The objective of this study was to determine whether this protective mechanism could be attributed to activity of the antiinflammatory cytokine interleukin (IL)-10. Design: Prospective, randomized, controlled study. Setting. Investigative intensive care unit at a medical university. Subjects: Female BALB-c mice, 10-12 wks of age (similar to 20 g). Interventions. All mice were subjected to intraperitoneal (ip) injection of lipopolysaccharide (LPS; Escherichia coli 0111:B4,125 jig). Mice were randomly assigned to the following groups: TNF-alpha, pretreated (100 mug ip 24 hrs before LPS); control (TNF vehicle alone 24 hrs before LPS); TNF/anti-IL-10 pretreated (TNF pretreatment as above and a neutralizing anti-IL-10 antibody); TNF/antiIL-10 control (TNF pretreatment as above and an isotype-matched control antibody with no IL-10 activity); IL-10 (100 mug ip 1 hr before LPS); and IL-10 control (IL-10 vehicle 1 hr before LPS). Measurements and Main Results: Mice were observed for a 48-hr period after endotoxin administration. Mortality in each group was recorded. Separate groups of mice were pretreated with TNF (or vehicle) and killed at 0, 2, or 4 hrs after LPS injection for collection of serum and peritoneal lavage samples that were used to assay IL-10 concentrations. A small dose of TNF-alpha attenuated mortality in mice that were subsequently injected with a highly lethal dose of endotoxin and observed for 48 hrs. Peritoneal lavage fluid concentrations of IL-10 were consistently higher in TNF-pretreated mice after endotoxin administration. The TNF-alpha protective effect was reversed by administration of a neutralizing antibody directed against murine IL-10. Conclusions. These findings indicate that administration of a low dose of TNF-alpha can induce cross-tolerance to endotoxin by induction of endogenous anti-inflammatory mechanisms.
引用
收藏
页码:1761 / 1766
页数:6
相关论文
共 57 条
[1]
p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial [J].
Abraham, E ;
Glauser, MP ;
Butler, T ;
Garbino, J ;
Gelmont, D ;
Laterre, PF ;
Kudsk, K ;
Bruining, HA ;
Otto, C ;
Tobin, E ;
Zwingelstein, C ;
Lesslauer, W ;
Leighton, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19) :1531-1538
[2]
SINGLE-DOSE TUMOR-NECROSIS-FACTOR PROTECTION AGAINST ENDOTOXIN-INDUCED SHOCK AND TISSUE-INJURY IN RATS [J].
ALEXANDER, HR ;
DOHERTY, GM ;
BLOCK, MI ;
KRAGEL, PJ ;
JENSEN, JC ;
LANGSTEIN, HN ;
WALKER, E ;
NORTON, JA .
INFECTION AND IMMUNITY, 1991, 59 (11) :3889-3894
[3]
TREATMENT WITH RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA PROTECTS RATS AGAINST THE LETHALITY, HYPOTENSION, AND HYPOTHERMIA OF GRAM-NEGATIVE SEPSIS [J].
ALEXANDER, HR ;
SHEPPARD, BC ;
JENSEN, JC ;
LANGSTEIN, HN ;
BURESH, CM ;
VENZON, D ;
WALKER, EC ;
FRAKER, DL ;
STOVROFF, MC ;
NORTON, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :34-39
[4]
A CRITICAL-EVALUATION OF NEW AGENTS FOR THE TREATMENT OF SEPSIS [J].
BONE, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (12) :1686-1691
[5]
BOTTOMS GD, 1985, CIRC SHOCK, V15, P155
[6]
Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD [J].
Bruce-Keller, AJ ;
Geddes, JW ;
Knapp, PE ;
McFall, RW ;
Keller, JN ;
Holtsberg, FW ;
Parthasarathy, S ;
Steiner, SM ;
Mattson, MP .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 93 (1-2) :53-71
[7]
CHERNOFF AE, 1995, J IMMUNOL, V154, P5492
[8]
TOLERANCE OF RATS TO HYPEROXIA - LUNG ANTIOXIDANT ENZYME GENE-EXPRESSION [J].
CLERCH, LB ;
MASSARO, D .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (02) :499-508
[9]
INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis [J].
Cohen, J ;
Carlet, J .
CRITICAL CARE MEDICINE, 1996, 24 (09) :1431-1440
[10]
PRETREATMENT WITH RECOMBINANT MURINE TUMOR NECROSIS FACTOR ALPHA-CACHECTIN AND MURINE INTERLEUKIN-1 ALPHA PROTECTS MICE FROM LETHAL BACTERIAL-INFECTION [J].
CROSS, AS ;
SADOFF, JC ;
KELLY, N ;
BERNTON, E ;
GEMSKI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (06) :2021-2027